Finance

Lists
RXO:NYSE
RXO Inc
$18.74
-4.24%
(-0.83) 1D
Sep 16, 10:45:40 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RXO...
Open
$19.26
High
$19.88
Low
$18.58
Mkt. cap
3.09B
Avg. vol.
1.65M
Volume
199.87K
52-wk high
$29.90
52-wk low
$10.42
EPS
-$0.62
Beta
1.98
Shares outstanding
164.93M
No. of employees
7K
Open
$19.26
High
$19.88
Low
$18.58
Mkt. cap
3.09B
Avg. vol.
1.65M
Volume
199.87K
52-wk high
$29.90
52-wk low
$10.42
EPS
-$0.62
Beta
1.98
Shares outstanding
164.93M
No. of employees
7K
News stories
From web sources and news partners
About RXO Inc
CEO-
Employees6.91K
Founded2022
HeadquartersCharlotte, North Carolina, United States
SectorIndustry
Websiterxo.com
Analyst ratings
Based on 16 analysts giving stock ratings to RXO in the past 3 months
Hold
Buy
6
Hold
7
Sell
3
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for RXO in the last 3 months.
Highest
Current $18.74
$35.00 (+86.77%)
Average
$25.50 (+36.07%)
Lowest
$17.50 (-6.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ariel Rosa
Citi
Hold
Maintained
$23.00
+22.7%
09/10/2026
Fadi Chamoun
BMO Capital
Buy
Reiterated
$35.00
+86.8%
09/10/2026
Ken Hoexter
Bank of America Securities
Hold
Reiterated
$27.00
+44.1%
09/10/2026
Christian Wetherbee
Wells Fargo
Hold
Reiterated
$23.00
+22.7%
09/10/2026
Lucas Servera
Truist Financial
Buy
Reiterated
$28.00
+49.4%
09/04/2026
Brian Ossenbeck
J.P. Morgan
Sell
Maintained
$22.00
+17.4%
08/10/2026
J. Bruce Chan
Stifel Nicolaus
Buy
Maintained
$31.00
+65.4%
08/11/2026
Thomas Wadewitz
UBS
Hold
Reiterated
$23.00
+22.7%
08/07/2026
Stephanie Moore
Jefferies
Buy
Reiterated
$30.00
+60.1%
08/07/2026
Jason Seidl
TD Cowen
Sell
Reiterated
$17.50
-6.6%
08/07/2026
Jeff Kauffman
Citizens JMP
Buy
Upgraded
$30.00
+60.1%
08/07/2026
Brandon Oglenski
Barclays
Buy
Maintained
$28.00
+49.4%
08/07/2026
Jordan Alliger
Goldman Sachs
Hold
Maintained
$20.00
+6.7%
07/16/2026
Unknown Analyst
Citizens JMP
Hold
Initiated
-
-
07/15/2026
Harrison Bauer
Susquehanna
Sell
Maintained
$20.00
+6.7%
07/14/2026
Reed Seay
Stephens
Hold
Initiated
$25.00
+33.4%
07/08/2026
Bascome Majors
Stephens
Hold
Initiated
$25.00
+33.4%
07/08/2026
Unknown Analyst
Raymond James
Hold
Maintained
-
-
07/02/2026
Ravi Shanker
Morgan Stanley
Hold
Downgraded
$22.00
+17.4%
05/08/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.06 / $0.04
+59.62%beat
Revenue / Est. (USD)
1.77B / 1.63B
+8.74%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.42B
1.47B
1.42B
1.77B
Cost of goods sold
1.18B
1.25B
1.22B
1.52B
Cost of revenue
1.18B
1.25B
1.22B
1.52B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
208.00M
200.00M
197.00M
211.00M
Operating expense
234.00M
228.00M
223.00M
237.00M
Total operating expenses
1.42B
1.48B
1.44B
1.76B
Operating income
2.00M
-9.00M
-19.00M
12.00M
Other non operating income
-
-
-3.00M
-
EBT including unusual items
-15.00M
-51.00M
-49.00M
-8.00M
EBT excluding unusual items
-7.00M
-18.00M
-31.00M
3.00M
Income tax expense
-1.00M
-5.00M
-13.00M
1.00M
Effective tax rate
6.67%
9.80%
26.53%
-12.50%
Other operating expenses
-
-
-
-
Net income
-14.00M
-46.00M
-36.00M
-9.00M
Net profit margin
-0.99%
-3.13%
-2.53%
-0.51%
Earnings per share
0.01
-0.07
-0.09
0.06
Interest and investment income
-
-
-
-
Interest expense
-9.00M
-9.00M
-9.00M
-9.00M
Net interest expenses
-9.00M
-9.00M
-9.00M
-9.00M
Depreciation and amortization charges
26.00M
28.00M
26.00M
26.00M
EBITDA
28.00M
19.00M
7.00M
38.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps